|
|
Post by itellthefuture777 on Mar 9, 2021 17:29:20 GMT -5
If only this revenge on Sanofi could happen! They certainly deserve a swift kick for what they did way back when. $10 billion upfront $They pay for pediatric clinical $77% of sales go to mnkd $33% of sales go to Sanofi (eu only) If Sanofi hits sales targets they can get milestone payments. If Sanofi wants 77% of Afrezza cough up $100 billion and hand mnkd 33% for..ever |
|
|
|
Post by itellthefuture777 on Mar 9, 2021 17:44:17 GMT -5
www.drugs.com/monograph/clofazimine.htmlClofazimine Class: Antimycobacterials, Miscellaneous VA Class: AM900 Chemical Name: N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methyethyl)imino]-2-phenazinamide Has been used for treatment of reversal (type 1) reactions† in patients with borderline or tuberculoid leprosy.2 37 71 81 Say what!?
|
|
|
|
Post by itellthefuture777 on Mar 9, 2021 18:02:27 GMT -5
www.drugs.com/monograph/clofazimine.htmlClofazimine Class: Antimycobacterials, Miscellaneous VA Class: AM900 Chemical Name: N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methyethyl)imino]-2-phenazinamide Has been used for treatment of reversal (type 1) reactions† in patients with borderline or tuberculoid leprosy.2 37 71 81 Say what!? |
|
|
|
Post by itellthefuture777 on Mar 9, 2021 18:07:41 GMT -5
trial number isrctn: Topics by Science.gov
... to achieve a dramatic therapeutic goal-a means to prevent and/or reverse type 1 diabetes. ... The nine-month regimen includes clofazimine and high-dose moxifloxacin and can be
|
|
|
|
Post by itellthefuture777 on Mar 9, 2021 18:10:29 GMT -5
trial number isrctn: Topics by Science.gov ... to achieve a dramatic therapeutic goal-a means to prevent and/or reverse type 1 diabetes. ... The nine-month regimen includes clofazimine and high-dose moxifloxacin and can be Type 1 "prevent" "reverse" Clofazimine.. Ughh...hello? This thing hits Covid-19..Type 1 diabetes..why are we under 1000 per share? |
|
|
|
Post by itellthefuture777 on Mar 9, 2021 20:04:36 GMT -5
trial number isrctn: Topics by Science.gov ... to achieve a dramatic therapeutic goal-a means to prevent and/or reverse type 1 diabetes. ... The nine-month regimen includes clofazimine and high-dose moxifloxacin and can be Type 1 "prevent" "reverse" Clofazimine.. Ughh...hello? This thing hits Covid-19..Type 1 diabetes..why are we under 1000 per share? MNKD-101 I can see why they made the acquisition so soon! That said thee NIH is funding it for TB. Surprised they didn't chase government grants for Covid-19 or the many other ailments Clofazimine seems to be key is solving like preventing or reversing type 1 diabetes..hmm |
|
|
|
Post by itellthefuture777 on Mar 9, 2021 20:29:11 GMT -5
I now see treatment TB is also Clofazamine and Azithromycin
Thought I saw an FDKP paper on that..out of China...hmm..also a China review asking if Clofazamine would work for Covid-19...hmm..maybe the China pharma company..hmmmm
|
|
|
|
Post by sellhighdrinklow on Mar 9, 2021 22:03:44 GMT -5
Maybe you are on to something and exactly why agedhippie and Matt are now 100% gone from these threads.
I always said, I kept buying more MNKD because of these silver-tongued(typed) commentators.
So far, so good.
|
|
|
|
Post by itellthefuture777 on Mar 9, 2021 22:25:01 GMT -5
I now see treatment TB is also Clofazamine and Azithromycin Thought I saw an FDKP paper on that..out of China...hmm..also a China review asking if Clofazamine would work for Covid-19...hmm..maybe the China pharma company..hmmmm Here it is...Fdkp Azithromycin China www.sciencedirect.com/science/article/abs/pii/S1001841720301893 |
|
|
|
Post by kc on Mar 9, 2021 23:20:34 GMT -5
Just read the transcripts from the conference call today. In my opinion Mike hit a grand slam. On seeking Alpha I posted the following comment.
Very good presentation by Mike. The future in my opinion looks to be very bullish. There’s a Lotta good things in the pipeline that will happen during the next 24 to 48 months.
The cloud that has hung over this company for many years should now be all blue sky. I believe that MannKind has a clear plan and long term shareholders like myself will eventually see PPS above $10 per share.
MannKind Corporation (MNKD) CEO Michael Castagna Presents at H.C. Wainwright Global Life Sciences Conference (Transcript)
|
|
|
|
Post by sr71 on Mar 10, 2021 0:52:53 GMT -5
I may well be mistaken, but I thought Mannkind had bought the rights to the FDKP molecule (Technosphere) many years ago before Afrezza was developed.
And I seriously doubt MC would be allowing others (especially foreign countries) to be developing on that platform without a formal partnership.
Afterall, Technosphere is supposed to be the golden goose.
|
|
|
|
Post by brentie on Mar 10, 2021 5:40:32 GMT -5
|
|
|
|
Post by itellthefuture777 on Mar 10, 2021 10:13:19 GMT -5
I may well be mistaken, but I thought Mannkind had bought the rights to the FDKP molecule (Technosphere) many years ago before Afrezza was developed. And I seriously doubt MC would be allowing others (especially foreign countries) to be developing on that platform without a formal partnership. Afterall, Technosphere is supposed to be the golden goose. No one ever ask in the calls..odd..hmm |
|
|
|
Post by longliner on Mar 10, 2021 10:27:36 GMT -5
Mike referenced the Denver facility twice in his presentation. This is the first time I have become aware we had a Denver facility?
Maybe I need to pay more attention to the company?
|
|
|
|
Post by hellodolly on Mar 10, 2021 10:41:06 GMT -5
Mike referenced the Denver facility twice in his presentation. This is the first time I have become aware we had a Denver facility? Maybe I need to pay more attention to the company? You are not alone. |
|
